Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.

Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB; Australian Technical Advisory Group on Immunisation (ATAGI) Meningococcal Working Party.

Med J Aust. 2017 Nov 6;207(9):382-387.

PMID:
29092704
2.

Australian Meningococcal Surveillance Programme, 1 January to 31 March 2017.

Lahra MM; for the National Neisseria Network, Australia.

Commun Dis Intell Q Rep. 2017 Jun 30;41(2):E201. No abstract available.

3.

Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.

Whiley DM, Trembizki E, Buckley C, Freeman K, Baird RW, Beaman M, Chen M, Donovan B, Kundu RL, Fairley CK, Guy R, Hogan T, Kaldor JM, Karimi M, Limnios A, Regan DG, Ryder N, Su JY, Ward J, Lahra MM.

Emerg Infect Dis. 2017 Sep;23(9):1478-1485. doi: 10.3201/eid2309.170427.

4.

Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.

Alirol E, Wi TE, Bala M, Bazzo ML, Chen XS, Deal C, Dillon JR, Kularatne R, Heim J, Hooft van Huijsduijnen R, Hook EW, Lahra MM, Lewis DA, Ndowa F, Shafer WM, Tayler L, Workowski K, Unemo M, Balasegaram M.

PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.

5.

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.

Wi T, Lahra MM, Ndowa F, Bala M, Dillon JR, Ramon-Pardo P, Eremin SR, Bolan G, Unemo M.

PLoS Med. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344. eCollection 2017 Jul.

6.

Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.

Lahra MM, Enriquez RP; Prince of Wales Hospital, Randwick, for The National Neisseria Network.

Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E109-E110. No abstract available.

7.

Australian Gonococcal Surveillance Programme annual report, 2015.

Lahra MM, Enriquez RP; National Neisseria Network.

Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E.

8.

Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016.

Lahra MM, Enriquez RP; Australian Meningococcal Surveillance Programme.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E447. No abstract available.

PMID:
28278420
9.

Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016.

Lahra MM, Enriquez RP; Australian Meningococcal Surveillance Programme.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E446. No abstract available.

PMID:
28278419
10.

Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia.

Lahra MM, Ward A, Trembizki E, Hermanson J, Clements E, Lawrence A, Whiley D.

Lancet Infect Dis. 2017 Feb;17(2):133-134. doi: 10.1016/S1473-3099(17)30007-5. No abstract available.

PMID:
28134103
11.

Australian Meningococcal Surveillance Programme, 1 July to 30 September 2016.

Lahra MM, Enriquez RP.

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E560. No abstract available.

12.

Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016.

Lahra MM, Enriquez RP.

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E557-E559. No abstract available.

13.

Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016.

Lahra MM, Enriquez RP.

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E554-E556. No abstract available.

14.

Australian Meningococcal Surveillance Programme annual report, 2015.

Lahra MM, Enriquez RP; National Neisseria Network.

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E503-E511.

15.

Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.

Martin NV, Ong KS, Howden BP, Lahra MM, Lambert SB, Beard FH, Dowse GK, Saul N; Communicable Diseases Network Australia MenW Working Group .

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E454-E459.

16.

Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.

Lahra MM, Trembizki E, Buckley C, Donovan B, Chen M, Guy R, Kundu RL, Regan DG, Whiley DM; GRAND Study Investigators.

J Antimicrob Chemother. 2017 Mar 1;72(3):705-711. doi: 10.1093/jac/dkw452.

PMID:
27999043
17.

Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience From Two Australian Tertiary Pediatric Facilities.

Bartlett AW, Smith B, George CR, McMullan B, Kesson A, Lahra MM, Palasanthiran P.

Pediatr Infect Dis J. 2017 Jan;36(1):20-24.

PMID:
27749655
18.

Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?

Goire N, Kundu R, Trembizki E, Buckley C, Hogan TR, Lewis DA, Branley JM, Whiley DM, Lahra MM.

J Antimicrob Chemother. 2017 Feb;72(2):407-409. doi: 10.1093/jac/dkw406. Epub 2016 Oct 5.

PMID:
27707989
19.

Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.

Trembizki E, Guy R, Donovan B, Kaldor JM, Lahra MM, Whiley DM; GRAND study investigators.

Lancet Infect Dis. 2016 Sep;16(9):1005-1006. doi: 10.1016/S1473-3099(16)30271-7. No abstract available.

PMID:
27684341
20.

The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012.

Trembizki E, Wand H, Donovan B, Chen M, Fairley CK, Freeman K, Guy R, Kaldor JM, Lahra MM, Lawrence A, Lau C, Pearson J, Regan DG, Ryder N, Smith H, Stevens K, Su JY, Ward J, Whiley DM.

Clin Infect Dis. 2016 Dec 15;63(12):1591-1598. Epub 2016 Sep 28.

PMID:
27682063

Supplemental Content

Loading ...
Support Center